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Abstract
Background: Each of the human genes or transcriptional units is likely to contain single nucleotide
polymorphisms that may give rise to sequence variation between individuals and tissues on the level
of RNA. Based on recent studies, differential expression of the two alleles of heterozygous coding
single nucleotide polymorphisms (SNPs) may be frequent for human genes. Methods with high
accuracy to be used in a high throughput setting are needed for systematic surveys of expressed
sequence variation. In this study we evaluated two formats of multiplexed, microarray based
minisequencing for quantitative detection of imbalanced expression of SNP alleles. We used a panel
of ten SNPs located in five genes known to be expressed in two endothelial cell lines as our model
system.
Results: The accuracy and sensitivity of quantitative detection of allelic imbalance was assessed for
each SNP by constructing regression lines using a dilution series of mixed samples from individuals
of different genotype. Accurate quantification of SNP alleles by both assay formats was evidenced
for by R2 values > 0.95 for the majority of the regression lines. According to a two sample t-test,
we were able to distinguish 1–9% of a minority SNP allele from a homozygous genotype, with larger
variation between SNPs than between assay formats. Six of the SNPs, heterozygous in either of the
two cell lines, were genotyped in RNA extracted from the endothelial cells. The coefficient of
variation between the fluorescent signals from five parallel reactions was similar for cDNA and
genomic DNA. The fluorescence signal intensity ratios measured in the cDNA samples were
compared to those in genomic DNA to determine the relative expression levels of the two alleles
of each SNP. Four of the six SNPs tested displayed a higher than 1.4-fold difference in allelic ratios
between cDNA and genomic DNA. The results were verified by allele-specific oligonucleotide
hybridisation and minisequencing in a microtiter plate format.
Conclusions: We conclude that microarray based minisequencing is an accurate and accessible
tool for multiplexed screening for imbalanced allelic expression in multiple samples and tissues in
parallel.
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Background
Single nucleotide polymorphisms (SNPs) are highly
abundant in the human genome, appearing on average at
0.1% of the nucleotide positions [1]. Thus, each gene or
transcriptional unit will contain multiple SNPs that
potentially give rise to sequence variation between indi-
viduals and tissues on the level of RNA. Recent studies
indicate that differences in the expression levels of the
alleles of heterozygous SNPs may occur frequently for
human genes [2-6]. Imbalanced allelic expression was
detected in foetal liver or kidney tissues for more than half
of 602 genes analysed, and one third of the genes dis-
played more than four-fold differences in allelic expres-
sion [3]. Another study detected lower levels of allelic
imbalance for one fifth of 129 genes analysed in lym-
phoblastoid cell lines [4].
Non-synonymous SNPs in coding regions of genes may be
functional by altering an amino acid, which in turn may
affect the structure and function of the encoded protein,
while synonymous SNPs may have functional conse-
quences by affecting the stability or folding of mRNA tran-
scripts. Intronic SNPs may give rise to alternatively spliced
mRNAs, while SNPs in 5'- or 3'-untranslated mRNA
regions may affect the stability or processing of the RNA.
Moreover, SNPs in non-protein coding regions of genes
that affect binding of regulatory factors may cause imbal-
anced expression of SNP alleles. This form of genetic var-
iation has been suggested as a common cause of both
normal and disease-related inter-individual variation in
complex phenotypes [7]. Clearly, methods with high
accuracy that can be used in a high throughput setting are
needed for systematic surveys of expressed sequence vari-
ation and its molecular causes.
Owing to the high sequence specificity of nucleotide
incorporation by DNA-polymerases, single nucleotide
primer extension has proven to allow quantitative deter-
mination of SNPs in genomic DNA in several studies and
assay formats (for a review, see Syvänen 2001 [8]). A fre-
quently used quantitative application of the method is to
determine SNP allele frequencies in pooled DNA samples
[9-13]. The rationale for detecting imbalanced expression
of the two alleles of a heterozygous SNP by minisequenc-
ing is to measure the ratio between the amounts of
labelled nucleotides incorporated in the minisequencing
reactions for the two SNP alleles in RNA (cDNA) samples
from the tissue of interest. These ratios are then compared
to the corresponding ratio measured in genomic DNA,
where the two alleles are present in an equimolar ratio
[2,4,14-16]. Imbalanced expression of the alleles of a SNP
is revealed by a difference in the ratios measured in the
RNA and DNA samples.
We are currently using microarray based minisequencing
for multiplex genotyping of SNPs. Our custom-made
microarrays permit the genotyping of up to 100 SNPs in
80 samples per standard microscope slide, either using
immobilised minisequencing primers [17,18] or using a
"tag-array" format [19,20] of the method [13]. The pur-
pose of this study was to evaluate the performance of
these two microarray formats in quantitative determina-
tion of SNP alleles on the RNA level as alternatives with
higher multiplexing capacity than previously used primer
extension methods in which the SNPs are analysed in
individual reactions. Using these systems, we were able to
detect significant differences in the amounts of the two
alleles of heterozygous SNPs on the RNA level.
Results
We used a panel of ten coding SNPs in five genes to
choose the optimal microarray based minisequencing
strategy for multiplex, quantitative genotyping of SNPs in
DNA and RNA samples. The selected SNPs were located in
genes shown by reverse transcriptase PCR analysis to be
expressed in one or both of two endothelial cells lines,
HUVEC (human umbilical vein endothelial cells) and
HAEC (human aortic endothelial cells) that served as our
model cell lines in this study (data not shown). We evalu-
ated two formats of microarray based minisequencing by
performing five parallel assays with each method for each
sample in the evaluation. The SNPs were analysed in both
DNA polarities and the evaluation of the methods was
based on the DNA polarity yielding the highest signal-to-
noise ratio.
In Method I, immobilised minisequencing primers are
extended with fluorescently labelled ddNTPs in reactions
performed on the microarray surface after annealing of
the multiplex PCR products to the primers [18,21]. In
Method II, cyclic primer extension reactions are per-
formed in solution in the presence of 5'-tagged minise-
quencing primers, PCR products and fluorescent ddNTPs
[22,23]. After the cyclic reactions the extended primers are
captured on a microarray surface carrying immobilised
oligonucleotides complementary to the 5'-tag sequences
on the minisequencing primers. Both these systems are
performed in an "array-of arrays" format developed previ-
ously in our laboratory [24].
We analysed a dilution series with mixtures of DNA from
two individuals with different genotypes for the panel of
ten SNPs in both DNA polarities. The genotyping results
from these mixtures of known amounts of the two SNP
alleles are expressed as the signal ratio between the fluo-
rescence signals corresponding to the two alleles of each
SNP. The quantitative analysis of these ten SNPs is illus-
trated in Figure 1 by regression lines, in which the mean
signal intensity ratios are plotted as a function of theBMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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Regression lines displaying accuracy and sensitivity of quantitative genotyping of SNPs Figure 1
Regression lines displaying accuracy and sensitivity of quantitative genotyping of SNPs. The regression lines were obtained by 
analysing ten SNPs in a series of mixed samples with varying amounts of DNA from two individuals of different genotype. The 
signal intensity ratios from minisequencing using immobilised primers (Method I, black diamonds) and "tag-array" minisequenc-
ing (Method II, grey squares) are plotted as a function of the known allelic ratios in the mixed samples. The SNP names are 
given in the panels. The signal intensity ratios are mean values of five replicate reactions. The signal intensity ratios obtained in 
homozygous samples (allele ratios zero) are indicated as black diamonds and grey squares on the left vertical axis of each panel.
Table 2: Results for the regression lines describing the accuracy and limit of detection for the methods when analysing mixed samples 
of a dilution series.
SNPa Methodb R2c Detection sensitivity (%)d p < 0.05 p-valuee
rs4331 ACE I 0.95 7.5 0.0076
II 0.97 4.9 0.0107
rs1042713 ADRB2 I 0.99 4.9 0.00051
II 0.98 2.1 0.000077
rs1042714 ADRB2 I 0.96 14 * 0.042
II 0.98 8.9 * 0.047
rs1042718 ADRB2 I 0.99 14 * 0.020
II 0.99 5.8 * 0.0011
rs1042719 ADRB2 I 0.90 5.8 0.0072
II 0.96 1.0 0.013
rs1799983 NOS3 I 0.99 8.9 * 0.0015
II 0.97 3.8 * 0.023
rs5351 EDNRB I 0.87 5.8 0.016
II 1.0 1.0 0.000016
rs5925 LDLR I 1.0 4.9 0.014
II 0.98 4.9 0.018
rs5930 LDLR I 0.94 8.9 0.00030
II 0.63 33 0.011
rs1433099 LDLR I 0.75 ND ND
II 0.88 5.8 0.017
a dbSNP ID number and gene name acronym.
b Minisequencing using (I) immobilised primers; (II) cyclic primer extension and "tag-arrays".
c Coefficient of determination describing the fit between the regression lines in Figure 1, and the data points.
d Level at which the minority SNP allele can be detected. The percentages correspond to the mixture with a signal intensity ratio significantly 
different (p < 0.05) from the signal intensity ratio of the corresponding homozygous or heterozygous (*) sample. ND: Not possible to determine 
due to scatter of the data points.
e p-value for difference between signal ratios at the detection level and at 0% of the minority allele.BMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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known allelic ratios in the mixed samples. The coefficient
of determination (R2), which describes how well the
regression line fits the data points, was used to assess the
accuracy of quantification of the SNP alleles by Methods I
and II. As can be seen in Table 2, the R2 values are close to
one for most of the SNPs analysed, demonstrating little
scatter of the data points around the regression line. For
Method I, six of the ten SNPs analysed have R2 values ≥
0.95, while for Method II the R2 values are ≥ 0.95 for eight
of the SNPs. Thus, accurate quantification of SNP alleles is
possible by both methods. The slopes of the regression
lines vary between the ten SNPs as well as between the two
methods (Figure 1). A regression line with a steep slope
usually corresponds to a high R2 value, as observed for the
SNP rs5930 LDLR analysed by Method I and SNP rs5331
EDNRB analysed by Method II. A flat slope does not nec-
essarily imply less accurate quantification, as exemplified
by the SNP rs4331 ACE, where Method II yielded a flat
slope with a higher R2 value than Method I.
We also determined the sensitivity of the methods for
detection of a minority allele. The detection limit was
defined as the percentage of the minority allele in the
mixed sample, for which the signal ratio differed from the
signal ratio in the corresponding homozygous sample
with a p-value < 0.05 in a two sample t-test. Depending on
the genotype of the DNA samples used for the dilution
series, determination of the lower limit of detection was
possible for seven of the ten SNPs with allele ranges 0–
50% or 0–100% in the mixed samples (Table 1). For the
remaining three SNPs with the allele range 50–100%, the
smallest percentage of an allele that could be distin-
guished from a heterozygous genotype was identified by
the same approach. Using Method I, we were able to
detect less than 5% of the minority allele for two SNPs
(rs1042713 ADRB2 and rs5925 LDLR) and less than 9%
for rs4331 ACE, rs1042719 ADRB2, rs5351 EDNRB and
rs5930 LDLR (Table 2). Method II allowed more sensitive
detection of minority alleles than Method I. Less than 2%
was detectable for the SNPs rs1042713 ADRB2,
rs1042719 ADRB2 and rs5351 EDNRB, and less than 9%
was detectable for the SNPs rs4331 ACE, rs5925 LDLR,
rs5930 LDLR and rs1433099 LDLR (Table 2). For the
SNPs rs1042714 ADRB2, rs1042718 ADRB2 and
rs1799983 NOS3, we were able to measure 4–14% devia-
tions from the heterozygous genotype (Table 2). These
results show that the amount of SNP alleles can be accu-
rately determined on the DNA level by Methods I and II
using reference samples with the two SNP alleles present
in known ratios.
Next, the performance of the two methods in quantitative
analysis on the RNA level was assessed. The ten SNPs were
first genotyped in genomic DNA (gDNA) from the
HUVEC and HAEC cells to identify those SNPs that were
heterozygous in either or both cell lines. Three SNPs in the
low density lipoprotein receptor gene (LDLR; rs5925,
rs5930 and rs1433099) were heterozygous in the HAEC
cell line, and one SNP in each of the genes encoding angi-
otensin I converting enzyme (ACE rs4331), β2-adrenergic
receptor (ADRB2 rs1042719) and endothelin receptor
type B (EDNRB rs5351) were heterozygous in the HUVEC
cell line. These SNPs were genotyped in cDNA produced
from total RNA extracted from the cells with the corre-
sponding gDNA as reference samples using both meth-
ods. Table 3 presents the mean fluorescence signals with
coefficients of variation (CV) obtained in five parallel
reactions for the six SNPs in cDNA and gDNA from the
HUVEC and HAEC cells. For the heterozygous SNPs the
largest difference in the variability between parallel reac-
tions was observed between SNPs, with the lowest CV val-
ues (3.6 – 8.6 %) for the rs1042719 ADRB2 SNP, and the
highest CV values (13 – 41%) for the rs1433099 LDLR
SNP. No systematic differences in the variability of
parallel reactions were observed between Method I and
Method II, or between cDNA and gDNA. Table 4 shows
the differences in mean signal intensity ratios between the
cDNA and gDNA assays for the six SNPs that were hetero-
zygous in HUVEC or HAEC cells, respectively, together
with the corresponding normalized cDNA/gDNA ratios.
The SNPs in the ACE, ADRB2 and EDNRB genes displayed
significant imbalanced expression in the HUVEC cells
using both methods. For the SNP rs4331 ACE, the signal
intensity ratio based on the raw data obtained by Methods
I and II differed from each other, but despite this large dif-
ference, both methods yielded similar levels of allelic
imbalance for this SNP after normalisation against the
signal ratio in gDNA (Table 4). Only for one of the three
LDLR SNPs (rs5930), the difference in fluorescence inten-
sity ratios between cDNA and gDNA from HAEC cells
reached statistical significance by both methods. Allelic
imbalance of the LDLR gene was detected for the LDLR
SNP rs5925 using Method II only.
To test that the results on imbalanced allelic expression
detected by the multiplexed microarray based methods
represents the true biological situation in the cells, we
analysed the heterozygous SNPs in five replicate RNA
samples prepared from HUVEC or HAEC harvested at dif-
ferent time points from different cell culture flasks. We
also analysed the three LDLR SNPs in five replicate reverse
transcription reactions from the same RNA sample pre-
pared from HAEC cells. For this analysis we used our first
generation solid-phase minisequencing assay for individ-
ual SNPs in a microtiter plate format. The concordant
cDNA/gDNA ratios from these control experiments from
independent cell and RNA samples presented in Table 5
show that the detected allelic imbalance was not caused
by the procedures for RNA extraction or cDNA synthesis.
Finally, we verified the results obtained by microarray-BMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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based minisequencing for three of the SNPs by real-time
PCR with allele specific hybridization probes (TaqMan).
Table 4 shows these results together with the correspond-
ing results by solid-phase minisequencing in a microtiter
plate format. Allelic imbalance was detected with statisti-
cal significance for the SNP rs1042719 ADRB2 and the
SNP rs1433099 LDLR by both methods. Particularly for
the SNP rs1042719 ADRB2, the cDNA/gDNA ratios
obtained by the two reference methods were highly simi-
lar to the results from the microarray-based methods pre-
sented in Table 4, as well as with each other. As for the
microarray-based Method II, the difference in signal ratios
between cDNA and gDNA measured by the TaqMan assay
for the SNP rs5925 LDLR did not reach statistical signifi-
cance due to large variation between parallel assays. Anal-
ysis of the SNP rs1433099 LDLR by the reference methods
confirms the imbalanced expression of the LDLR receptor
alleles.
Discussion
The purpose of our study was to evaluate microarray
based minisequencing for multiplexed detection and
Table 1: SNP genotypes of the DNA samples used for preparing the dilution series for the quantification curves.
SNPa Sample 1 Sample 2 Allele rangeb
rs4331 ACE TT CC 0–100% T
rs1042713 ADRB2 AA GG 0–100% A
rs1042714 ADRB2 CC CG 50–100% C
rs1042718 ADRB2 CC CA 50–100% C
rs1042719 ADRB2 CG GG 0–50% C
rs1799983 NOS3 CC CA 50–100% C
rs5351 EDNRB GA AA 0–50% G
rs5925 LDLR TT CC 0–100% T
rs5930 LDLR TC CC 0–50% T
rs1433099 LDLR TC CC 0–50% T
a SNP name consisting of dbSNP ID number and gene name acronym.
b The percentages of the allele from Sample 1 in the dilution series with the 0–100% allele range were: 0%; 2.1%; 4.9%; 7.5%; 11.6%; 17.9%; 27.5%; 
42.3%; 65%; 100%. The corresponding percentages in the 0–50% allele range were 0%; 1.0%; 2.5%; 3.8%; 5.8%; 8.9%; 13.7%; 21.1%; 32.5%; 50%, and 
in the 50–100% allele range they were 50%; 51.3%; 52.5%; 53.8%; 55.8%; 58.9%; 63.7%; 71.1%; 82.%; 100%.
Table 3: Fluorescence signals obtained by genotyping six SNPs in RNA (cDNA) and genomic DNA from the HUVEC and HAEC cells 
using the two minisequencing methods.
Fluorescence signal (CV %)b Fluorescence signal 
ratioc
cDNA gDNA cDNA gDNA
SNPa Method Allele 1 Allele 2 Allele 1 Allele 2
rs4331 I 17975 (31%) 4428 (20%) 17568 (12%) 10291 (10%) 4.1 1.7
ACE II 20447 (37%) 21796 (11%) 8928 (35%) 26913 (18%) 0.94 0.33
rs1042719 I 14368 (12%) 28538 (25%) 21179 (11%) 22192 (12%) 0.50 0.95
ADRB2 II 11475 (3.6%) 34346 (5.4%) 18495 (7.4%) 39569 (8.6%) 0.33 0.47
rs5351 I 11026 (10%) 1743 (15%) 7344 (16%) 2077 (17%) 6.3 3.5
EDNRB II 65257 (0%) 7484 (14%) 64360 (3.3%) 11552 (20%) 8.7 5.6
rs5925 I 13984 (25%) 16040 (5.7%) 9586 (32%) 9329 (20%) 0.87 1.0
LDLR II 3504 (27%) 9582 (14%) 1951 (10%) 7113 (8.2%) 0.37 0.27
rs5930 I 5680 (13%) 5028 (13%) 7207 (22%) 9244 (17%) 1.1 0.78
LDLR II 5410 (31%) 9965 (15%) 3261 (27%) 11183 (9.0%) 0.54 0.29
rs1433099 I 8806 (20%) 4594 (10%) 7307 (32%) 3646 (23%) 2.0 2.0
LDLR II 2550 (41%) 4507 (16%) 1727 (36%) 3743 (13%) 0.57 0.46
a rs4331 ACE, rs1042719 ADRB2 and rs5351 EDNRB were analysed in HUVEC and rs5925 DLR, rs5930 LDLR and rs1433099 LDLR were analysed 
in HAEC.
b Mean values and coefficient of variation (CV) of five parallel minisequencing assays from the same PCR product.
c The homozygous signal intensity ratios were 0.0027 for rs4331 ACE, 0.0094 for rs1042719 ADRB2, and 0.10 for rs5351 EDNRB in gDNA from 
HAEC, and 0.0069 for rs5925 LDLR, 0.0056 for rs5930 LDLR, and 0.014 for rs1433099 LDLR in gDNA from HUVEC.BMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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quantification of imbalanced expression of SNP alleles, as
a prelude to further large scale screening for allelic imbal-
ance. We found no significant differences in the perform-
ance of our two "in house" methods, minisequencing
with primers directly immobilised on the microarrays
(Method I)[18] and the "tag-array" format, based on
cyclic minisequencing followed by capture on microar-
rays using immobilised complementary "tag" probes
(Method II) [23]. Both methods showed a linear relation-
ship between SNP allele ratios and the signal intensity
measured in the four-colour fluorescence minisequencing
assay for all SNPs. With respect to accuracy assessed by
coefficients of variation (CV) between five parallel assays
both methods performed equally well, and the CV values
between parallel assays were indistinguishable between
genomic DNA and reverse transcribed cDNA samples. The
sensitivity of detecting a SNP allele present as a minority
in a sample was defined as the percentage for which the
signal ratio differed from the signal ratio in the corre-
sponding homozygous sample with a p-value < 0.05 in a
two sample t-test. The sensitivity differed between SNPs,
and range from 1% to 9%, with a trend to be slightly bet-
ter using the "tag-array" system (Method II). In several
cases the p-values were lower than 0.05 (Table 2), which
Table 4: Fluorescence signal intensity ratios obtained by genotyping six SNPs in RNA (cDNA) and genomic DNA from the HUVEC and 
HAEC cells using the two microarray-based minisequencing methods and two reference methods.
Fluorescence signal ratio Difference in cDNA and gDNA ratios
(p-value)
cDNA/gDNAc
SNPa Methodb cDNA gDNA
rs4331 ACE I 4.1 1.7 0.00095 2.4 (1.9–2.8)
II 0.94 0.33 0.0060 2.8 (1.8–4.0)
rs1042719 ADRB2 I 0.50 0.95 0.000025 0.54 (0.47–0.69)
II 0.33 0.47 0.0070 0.71 (0.67–0.75)
TM 0.086 0.19 <0.0001 0.47 (0.31–0.56)
MS 0.48 0.99 <0.0001 0.48 (0.34–0.62)
rs5351 EDNRB I 6.3 3.5 0.00014 1.8 (1.6–2.0)
II 8.7 5.6 0.0030 1.6 (1.4–1.8)
rs5925 LDLR I 0.87 1.0 0.33 0.85 (0.63–1.1)
II 0.37 0.27 0.029 1.4 (1.1–1.5)
TM 3.3 1.4 0.15 2.4 (1.4–5.6)
MS 0.36 0.28 0.027 1.3 (0.98–1.5)
rs5930 LDLR I 1.1 0.78 0.035 1.5 (1.1–1.9)
II 0.54 0.29 0.0030 1.8 (1.5–2.3)
rs1433099 LDLR I 2.0 2.0 0.66 0.96 (0.84–1.1)
II 0.57 0.46 0.33 1.2 (0.65–1.5)
TM 1.0 0.49 <0.0001 2.0 (1.9–2.1)
MS 0.47 0.32 0.060 1.5 (1.0–2.0)
a rs4331 ACE, rs1042719 ADRB2 and rs5351 EDNRB were analysed in HUVEC and rs5925 LDLR, rs5930 LDLR and rs1433099 LDLR were 
analysed in HAEC.
b Minisequencing using (I) immobilised primers; (II) cyclic primer extension and "tag-arrays", TaqMan (TM) and solid-phase minisequencing (MS). TM-
assays were not possible to design using the Assay-by-Design and Assay-on-Demand service at ABI for the remaining three SNPs, MS was 
performed for the SNPs with working TM-assays.
c Mean and range is given for five parallel reactions.
Table 5: Test of allelic imbalance in replicate RNA-preparations 
and cDNA samples.
cDNA/gDNA ratios in replicate RNA preparations a
rs4331 ACE rs1042719 ADRB2 rs5351 EDNRB
HUVEC 2.8 (1.4 – 4.0) 0.48 (0.34 – 0.62) 1.2 (1.1 – 1.4)
rs5925 LDLR rs5930 LDLR rs1433099 LDLR
HAEC 1.3 (0.98 – 1.5) 1.6 (1.0 – 2.3) 1.5 (1.0 – 2.0)
cDNA/gDNA ratios in replicate cDNA samples b
rs5925 LDLR rs5930 LDLR rs1433099 LDLR
HAEC 1.5 (1.3 – 1.7) 1.9 (1.7 – 2.4) 1.1 (0.87 – 1.4)
Average cDNA/gDNA ratios from five replicate experiments with 
range of variation in parantheses.
a cDNA synthesised from RNA extracted from five different cell 
batches analysed in duplicate using solid-phase minisequencing assays 
in a microtiter plate format.
b Five replicate cDNA samples were reverse transcribed from the 
same RNA preparation and analysed in duplicate assays.BMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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indicates that in practice the sensitivity of detection would
be lower than the stringent limit set here. The sensitivity
of our multiplex microarray based minisequencing meth-
ods compares well with the sensitivity of other single
nucleotide primer extension assays performed for individ-
ual SNPs in recent studies [4,25-27].
It is notable that the largest differences in accuracy and
sensitivity were observed between SNPs. Some of the SNP-
to-SNP differences are likely due to differences is the accu-
racy and efficiency of incorporation of the four different
fluorescently labelled nucleotide analogues by the DNA
polymerase [13,26] as well as to other sequence context
dependent factors. The large variation between parallel
assays for the SNP rs1433099 LDLR prevented detection
of the allelic imbalance for the LDLR gene, while imbal-
ance was detected by the SNP rs5930 LDLR using both
methods. This result demonstrates that it is preferable to
analyse more than a single SNP in each gene in systematic
screening for allelic imbalance in gene expression. As
more data from primer extension assays accumulate, it
may be possible to improve the accuracy of the system by
improving the SNP selection and assay design further with
the aid of algorithms developed based on this data
[28,29].
Comparison of the relative amounts of the alleles of six
SNPs on the RNA (cDNA) level to heterozygote SNPs in
genomic DNA revealed four SNPs with imbalanced
expression of the two alleles. A three-fold increase in the
expression of the T-allele for the SNP rs4331 ACE was the
most pronounced difference observed. In our study, 1.4–
1.5-fold differences in allelic expression levels were detect-
able. The sensitivity of detecting a minority allele in our
system would allow the distinction between 10-fold
reduction in the expression of an allele and monoallelic
expression, for example as a result of imprinting. Owing
to its potential for high throughput screening of large
numbers of samples, we have also performed a prelimi-
nary evaluation of the commercial SNPstream genotyping
system (GenomeLab, Beckman Coulter) that also utilises
the "tag-array" primer extension strategy in a semi-auto-
mated 384-well microtiter plate format for detection of
imbalanced allelic expression [30]. The same trend of
imbalanced allelic expression was observed for each of the
SNPs, which is encouraging for future studies of imbal-
anced allelic expression in a high throughput semi-auto-
mated way. Other studies that have used fluorescent
single base primer extension assays report that 1.2 – fold
to 1.5 – fold differences in allelic expression are detectable
[2,4,5]. Primer extension methods based on direct meas-
urement of fluorescent signals, including the microarray-
based methods evaluated here, are likely to provide better
accuracy and sensitivity for allele quantification than
homogeneous primer extension based on fluorescence
polarisation [31,32], in which the allele quantification
relies on measurement of small differences between large
polarization signals.
It is also reassuring for future large scale detection of
imbalanced allelic expression that the accuracy of our
methods seemed to be similar for cDNA and genomic
DNA. Analysis of replicate RNA samples from different
batches of both cell lines using a microtiter plate format
of the minisequencing method evidenced for the biologi-
cal authenticity of the allelic imbalance detected using
minisequencing in the microarray format. The data
obtained from independent cell samples also indicate an
acceptable reproducibility of RNA extraction, RNA storage
and cDNA synthesis. Another important factor besides
sample to sample variation that may affect the accuracy of
the relative allele quantification is the amount of mRNA
subjected to the analysis. At a low copy number of mRNA,
the stochastic distribution of the RNA templates may be a
major source of variation [33]. The reason for the large
variation between parallel assays for the LDLR receptor
gene observed with all four methods used in our study
may reflect a low expression level of the LDLR gene in the
HAEC cells. Moreover, the amount of gene specific tran-
script in each RNA sample may vary which makes it diffi-
cult to perform balanced multiplex RT-PCRs to screen for
allelic imbalances in several genes in one reaction.
A similar minisequencing strategy as the one used for
determination of imbalanced expression between SNP
alleles can also be used for determination of the relative
expression levels of highly homologous genes [15] and for
determination of alternatively spliced transcripts [34], a
resolution that is beyond the capacity of traditional
microarray based RNA expression profiling.
Conclusions
Here we demonstrated the applicability of two formats of
microarray based minisequencing for detecting imbal-
anced expression of SNP alleles. The accuracy and sensi-
tivity of both systems allow detection of 1.4- to 10-fold
differences in the expression levels of the two alleles of
heterozygous SNPs. The microarray-based minisequenc-
ing systems utilise widely available reagents and equip-
ment, and can thus easily be established "in-house".
Moreover, the system is flexible with respect to number of
SNPs and samples to be analyzed. Systematic quantitative
screening of genetic diversity on the RNA level in multiple
individuals and tissues will be a future approach in the
elucidation of the molecular mechanisms that regulate
gene expression.BMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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Methods
DNA and RNA samples
DNA samples from 30 volunteer donors were genotyped
by Methods I and II to identify individuals of different
genotypes for the panel of ten SNPs analysed. The SNPs
are described in the section "SNPs and primers" below.
DNA (10 ng/µl) from one individual was serially diluted
2:1 into DNA (10 ng/µl) from a second individual, to
yield a series of DNA samples with different ratios
between the SNP alleles. These mixed DNA samples were
used for construction of quantification standard curves.
Depending on the genotype of each SNP in the two indi-
viduals whose DNA was mixed, dilution series of samples
with different allelic ranges were obtained for the ten
SNPs, as specified in Table 1.
Human Umbilical Vein Endothelial Cells (HUVEC) and
Human Aortic Endothelial Cells (HAEC) (Cascade Bio-
logics, Inc., Portland, OR, USA) were grown in Medium
200 with Low Serum Growth Supplement (LSGS Kit,
Cascade Biologics, Inc., Portland, OR, USA) at 37°C in a
humidified atmosphere of 5% CO2. Cells from the cul-
tures were harvested at 80% confluence according to the
manufacturer's instructions. Total RNA was isolated from
the cells using the TRIZOL®Reagent (GIBCO BRL, Paisley,
Scotland) and the RNA samples were stored at -70°C until
use. High quality RNA with A260/A280 ratio over 1.9 and
intact ribosomal 28S and 18S RNA were used for cDNA
synthesis. The RNA samples were treated with 1 U RQ1
RNase-free DNase (Promega, Madison, WI, USA) per µg
RNA. Two to 2.5 µg total RNA was subjected to first strand
cDNA synthesis using SuperScript™ II (RNase H- Reverse
Transcriptase, Invitrogen, Carlsbad, CA, USA) reagents in
a 20 µl volume. DNA was extracted from the cells using
GenElute™ Mammalian Genomic DNA Kit (Sigma, St
Louis, MO, USA) and stored at -20°C until use.
PCR
The fragments comprising the SNPs were PCR-amplified
in individual reactions using 10–15 ng genomic DNA or
one tenth of the cDNA products, 0.2 mM dNTPs, 1U
AmpliTaq ® Gold DNA polymerase (Applied Biosystems,
Foster City, CA, USA), 1.5 mM MgCl2, and 0.2–0.3 µM of
primers in 50 µl of 10 mM Tris-HCl pH 8.3 and 50 mM
KCl. The PCR conditions were initial activation of the
enzyme at 95°C for 10 min followed by 35 cycles of 95°C
for 1 min, 56°C for 1 min and 72°C for 1 min and a final
extension at 72°C for 7 min in a Thermal Cycler PTC225
(MJ Research, Watertown, MA, USA). The amplified frag-
ments were combined and concentrated to 60 µl using
Microcon  ® YM-30 Centrifugal Filter Devices (Millipore
Corporation, Bedford, MA, USA).
SNPs and primers
Ten SNPs located in coding regions of genes known to be
expressed in HUVEC and HAEC cells were analysed. Infor-
mation on the SNPs, including dbSNP [35] ID number
and nucleotide variation is given [see Additional file 1]
together with the sequences of the minisequencing prim-
ers. The primers for PCR and minisequencing were
designed using the Oligo Primer Analysis software v6.65
(Molecular Biology Insights Inc., Cascade, CO, USA).
Preparation of microarrays
The minisequencing primers or the complementary tag-
oligonucleotides were covalently immobilised on Code-
Link™ Activated Slides (Amersham Biosciences, Uppsala,
Sweden) by the mediation of a NH2-group in their 5'- or
3'-end, respectively. The oligonucleotides were applied in
duplicates to the slides at a concentration of 25 µM in 150
mM sodium phosphate pH 8.5 using a ProSys 5510A
instrument (Cartesian Technologies Inc, Irvine. CA, USA)
equipped with one Stealth Micro Spotting pin (SMP3B,
TeleChem International Inc., Sunnyvale, CA, USA) to
minimise the variation between spots in different "subar-
rays". The oligonucleotides were spotted in an "array-of-
arrays" configuration that facilitates analysis of 80 indi-
vidual samples in parallel on each microscope slide [24].
In each "subarray" a fluorophore-labelled oligonucleotide
was included as a control for the immobilisation process.
A reference oligonucleotide, complementary to a syn-
thetic template included in the minisequencing reaction
mixtures to monitor the difference in incorporation effi-
ciency of the four nucleotides by the DNA polymerase,
was also included in each "subarray". Finally, an oligonu-
cleotide designed not to hybridise to any of the oligonu-
cleotides present in the reaction mixture was included in
each "sub-array" to be used for background corrections.
After printing, the slides were incubated in a humid cham-
ber for at least 24 hours, followed by treatment with eth-
anolamine according to the manufacturer's instruction.
The slides were then stored desiccated in the dark until
use.
Minisequencing using immobilised primers (Method I)
Aliquots of 7.5 µl of the concentrated PCR products were
analysed in five parallel "subarrays" for each sample,
essentially as described previously [18]. The PCR products
were allowed to anneal to the immobilised oligonucle-
otides. After washing, the extension reactions were per-
formed with 0.75 U of Thermo Sequenase™ DNA
polymerase (Amersham Biosciences, Uppsala, Sweden)
and 0.35 µM Texas Red-ddATP, Tamra-ddCTP, R110-
ddGTP and Cy5-ddUTP (Perkin Elmer Life Sciences, Bos-
ton, MA, USA) in Thermo Sequenase™ reaction buffer in a
total volume of 15 µl, followed by washing of the slide.BMC Biotechnology 2004, 4:24 http://www.biomedcentral.com/1472-6750/4/24
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Minisequencing using "tag-arrays" (Method II)
Five parallel reactions with a 4.5 µl aliquot of the concen-
trated PCR products were analysed for each sample, as
described in detail in [23]. Excess of PCR primers and
dNTPs were removed by treatment with 5 U of exonucle-
ase I and 1 U of shrimp alkaline phosphatase (USB Cor-
poration, Cleveland, OH, USA). The cyclic
minisequencing reactions were performed in the presence
of the 20 tagged primers at 10 nM concentration, 0.1 µM
Texas Red-ddATP, Tamra-ddCTP and R110-ddGTP, 0.2
µM Cy5-ddUTP (Perkin Elmer Life Sciences, Boston, MA,
USA) and 1 U of Thermo Sequenase™ DNA polymerase
(Amersham Biosciences, Uppsala, Sweden) for 55 cycles
of 95°C and 55°C for 20 s each. The extension products
were allowed to anneal to the immobilised complemen-
tary tag oligonucleotides at 42°C for 2.5 hours followed
by washing of the slide.
Solid-phase minisequencing in a microtiter plate format
PCR was run with one of the primers biotinylated. The
biotinylated PCR products were immobilised in a micro-
titer plate coated with streptavidin (Combiplate 8, Labsys-
tems, Helsinki, Finland) and the unbiotinylated strand
was removed with alkali treatment [9,15]. The minise-
quencing mixture, containing the appropriate tritium
labelled dNTP (Amersham Biosciences, Uppsala, Swe-
den), AmpliTaq ® DNA polymerase (Applied Biosystems,
Foster City, CA, USA) and the minisequencing primer was
added. The extension reaction was allowed to proceed for
10 min at 50°C. The extended primers were released with
alkali and the amount of incorporated tritium labelled
nucleotide was measured.
Hybridisation with allele-specific TaqMan probes
Primers and probes for the TaqMan assays were designed
by Applied Biosystems as Assay-by-Design (rs1042719
ADRB2 and rs5925 LDLR) or Assay-on-Demand
(rs1433099 LDLR) service. The probes for the two alleles
were labelled with the reporter dyes FAM and VIC
respectively. The sequences of the primers and probes for
the SNPs rs5925 LDLR and rs 1042719 ADRB2 are found
in [Additional file 1]. The primer and probe sequences for
the SNP rs1433099 LDLR were not made available to us
by ABI since this SNP is included in their Assay-on-
Demand program.
Real time quantitative PCR was run in 25 µl TaqMan Uni-
versal PCR Master Mix (Applied Biosystems) with 200 nM
of both labelled TaqMan probes, 900 nM PCR-primers
and 10 ng genomic DNA or one tenth of the cDNA prod-
ucts. The PCR conditions were initial activation of the
enzyme at 95°C for 10 min followed by 60 cycles of 95°C
for 15 sec and 60°C for 1 min in a ABI7000 instrument
(Applied Biosystems, Foster City, CA, USA).
The signal intensity ratios were calculated based on nor-
malised ∆Rn fluorescence values obtained from the assay
during the exponential phase of PCR. The ∆Rn values were
retrieved from cycle 38 for the SNP rs1042719 ADRB2,
cycle 42 for the SNP rs5925 LDLR and cycle 43 for the SNP
rs1433099 LDLR. Imbalanced expression of the SNP alle-
les was determined by a t-test as described below.
Signal detection and data analysis
In Methods I and II fluorescence was measured using a
ScanArray  ® Express instrument (Perkin Elmer Life Sci-
ences, Boston, MA, USA) with the excitation lasers Blue
Argon 488 nm, Green HeNe 543.8 nm, Yellow HeNe 594
nm and Red HeNe 632.8 nm with the laser power set to
80% and the photomultiplier tube gain adjusted to obtain
equal signal intensities from reaction control spots for all
four spectra. The fluorescence signals were extracted using
the QuantArray ® analysis 3.1 software (Perkin Elmer Life
Sciences, Boston, MA, USA). The mean of the fluorescence
signals for the duplicate spots was corrected for the aver-
age background in each "sub-array" separately. The data
was handled and interpreted using the Microsoft ® Excel
program.
The genotype for each individual SNP was assigned by cal-
culating a ratio between the fluorescence signals for the
two alleles. Coefficients of determination (R2) were
assigned by linear regression analysis of the relationship
between the signal intensity ratios determined from the
minisequencing assay and the known allelic ratios in the
mixed samples for the quantification standard curves.
Two-sample t-tests with two-tailed significance levels
assuming unequal variance were performed to determine
the lowest level of detection of a specific allele for the
quantification standard curves and to evaluate the imbal-
anced expression of the two alleles of the SNPs in the cell
lines.
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